Startup's blood test aims to predict which cancer patients will react better to treatment; 8 clinical trials will be set up in the UK

Risk of some cancers may be reduced by boosting production of a single enzyme in the body, which in turns keeps BRD4 protein in check, say Ben Gurion University scientists

BioNTech's Ozlem Tureci says the know-how behind revolutionary inoculations could soon be used to treat far more than the coronavirus pandemic

Hebrew University team says foods including black tea, berries and chocolate could abet tumor growth by aiding mutated proteins in colon

Rehovot-based oncology company develops drugs to treat rare and aggressive cancers, files prospectus for New York offering

ONCOHOST, founded by the Technion's Yuval Shaked, is performing clinical trials; goal is to predict treatments' effectiveness and determine how to improve them, for each patient

aMoon fund, a health-tech fund, makes a $5 million investment in venture set up by Technion's Marcelle Machluf to commercialize tumor-busting technology

PJ34, a stroke therapy, is seen to offer 'great potential' for causing the aggressive tumor, as well as others, to self-destruct in humans, Tel Aviv University researchers say

Israeli researchers discover specific type of white blood cells thatcan be engineered to attack solid tumors, with fewer side effects than chemotherapy

Weizmann Institute researchers find the more cancer cells differ from one another, the less effective immunotherapies are; they hope ultimately to create personalized treatments